Organogenesis Holdings Inc. ORGO Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s financing cash flow?
- Organogenesis Holdings Inc. (ORGO) reported financing cash flow of -$20.21M in Q1 2026.
- How has Organogenesis Holdings Inc.'s financing cash flow changed year-over-year?
- Organogenesis Holdings Inc.'s financing cash flow decreased by 883.1% year-over-year, from -$2.06M to -$20.21M.
- What is the long-term trend for Organogenesis Holdings Inc.'s financing cash flow?
- Over 2 years (2023 to 2025), Organogenesis Holdings Inc.'s financing cash flow has grown at a 77.6% compound annual growth rate (CAGR), from -$5.51M to -$17.36M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.